BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9218193)

  • 1. Low-dose combinations versus monotherapies in the treatment of hypertension.
    Waeber B; Brunner HR
    J Hypertens Suppl; 1997 Mar; 15(2):S17-20. PubMed ID: 9218193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
    Waeber B
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the use of very-low-dose combinations as first-line treatment of hypertension.
    Waeber B; Brunner HR
    J Hypertens Suppl; 2001 Nov; 19(4):S3-8. PubMed ID: 11848261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multifactorial nature of hypertension: the greatest challenge for its treatment?
    Waeber B; Brunner HR; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S9-16. PubMed ID: 11713851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose fixed combination of bisoprolol/hydrochlorothiazide as first line for hypertension: a review of the rationale and clinical evidence.
    Papadopoulos DP; Papademetriou V
    Angiology; 2009; 60(5):601-7. PubMed ID: 19028769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?
    Struijker-Boudier HA; Ambrosioni E; Holzgreve H; Laurent S; Mancia G; Ruilope LM; Waeber B
    Int J Clin Pract; 2007 Sep; 61(9):1592-602. PubMed ID: 17686100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment strategies in essential arterial hypertension].
    Waeber B
    Rev Prat; 1999 Mar; 49(5):520-5. PubMed ID: 10358402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed drug combinations in the treatment of hypertension: how to identify the optimal dose.
    Messerli FH; Michalewicz L
    J Hypertens Suppl; 1998 Jan; 16(1):S81-4. PubMed ID: 9534103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination versus Monotherapy as Initial Treatment in Hypertension.
    Holzgreve H
    Herz; 2003 Dec; 28(8):725-32. PubMed ID: 14689107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When antihypertensive monotherapy fails: fixed-dose combination therapy.
    Weir MR
    South Med J; 2000 Jun; 93(6):548-56. PubMed ID: 10881767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan/hydrochlorothiazide: a new fixed dose combination.
    Maillard M; Burnier M
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):375-86. PubMed ID: 15889965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fixed-dose combinations in the first line of antihypertensive therapy].
    Urbán L; Mészáros A
    Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].
    González Maqueda I; Gómez Guindal JA; González Lama I
    Rev Esp Cardiol; 1999; 52 Suppl 3():59-72. PubMed ID: 10614151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy as first-line treatment of arterial hypertension.
    Ruzicka M; Leenen FH
    Can J Cardiol; 2002 Dec; 18(12):1317-27. PubMed ID: 12518184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed low-dose combination in first-line treatment of hypertension.
    Prisant LM
    J Hypertens Suppl; 2002 Feb; 20(1):S11-9. PubMed ID: 11996195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.